Indian American’s Company granted “Breakthrough Device Designation” from FDA for its Sirolimus coated Catheter

Indian American cardiologist and entrepreneur Dr. Kiran Patel is well known for philanthropy efforts, globally

TAMPA, FL (TIP): Indian American cardiologist and entrepreneur Dr. Kiran Patel’s company Concept Medical Inc. (CMI) has been granted ‘Breakthrough Device Designation’ from the US Food and Drug Administration (FDA) last month for MagicTouch, its sirolimus drug-coated balloon (DCB) catheter, for the treatment of coronary in-stent restenosis (ISR).

The goal of the FDA ‘Breakthrough Devices Program’ is to provide patients and health-care providers in the US with timely access to these medical devices by speeding up their development, assessment, and review, while preserving the statutory standards for premarket approval, 510(k) clearance, and De Novo marketing authorization, consistent with the Agency’s mission to protect and promote public health.

The Breakthrough Devices Program offers manufacturers an opportunity to interact with the FDA’s experts through several different program options to efficiently address topics as they arise during the premarket review phase, which can help manufacturers receive feedback from the FDA and identify areas of agreement in a timely way. Manufacturers can also expect prioritized review of their submission. Under the program, FDA will provide CMI with priority review and interactive communication regarding device development and clinical trial protocols, through to commercialization decisions.

“The FDA’s designation of MagicTouch for the Breakthrough Device Program will allow CMI to meet its ambition to provide this promising technology and innovative treatment for ISR patients in the USA. Our confidence in MagicTouch emanates from the positive feedback that we are receiving from the users of our product from current and ongoing commercial sales of MagicTouch in many European countries” said cardiologist Dr. Kiran Patel, Chairman of CMI. “CMI is encouraged that the selection of MagicTouch, with its unique drug delivery technology, for the FDA’s Breakthrough Device Program may allow timely access of this promising new technology to the US patients with coronary ISR with a potential to provide safe and effective treatment”, he further added.

Dr. Patel is the Founder and Chairman of the ‘Drs. Kiran and Pallavi Patel Family Foundation‘, well known for their philanthropy efforts, globally.

Be the first to comment

Leave a Reply

Your email address will not be published.


*